Insider · CIK 0001926290
John D. Yee
Files at TPST (Tempest Therapeutics, Inc.). First filing -, latest -.
In brief
John D. Yee files SEC Form 4 as director at TPST (Tempest Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John D. Yee has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | TPST Tempest Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 17, 2026 |
Questions about John D. Yee
Answered from the filings on this page, as of the latest one.
Is John D. Yee buying or selling?
John D. Yee has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John D. Yee's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John D. Yee has 0.
Where does John D. Yee file Form 4?
John D. Yee has filed Form 4 at TPST (Tempest Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.